Effects of the physiotherapy in the motor functions and quality of life in Parkinson's disease

Effects of a physiotherapy treatment protocol for motor functions and quality of life in Parkinson's disease: experimental study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

REBEC

Registry ID

RBR-392cxdp

Enrollment

Unknown

Registered

2022-08-19

Start date

2017-10-01

Completion date

Unknown

Last updated

2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Interventions

Intervention and control groups received the following interventions: a) OGEI-1x: observed group, exposed to group physical therapy intervention once a week, each session lasting 40 minutes. This grou

b) EG-C (experimental group, control phase): group monitored and treated by the research team, control period. This group had 6 participants and was evaluated three times over time. However, between t

E02.779

Eligibility

Age

40 Years to 70 Years

Inclusion criteria

Inclusion criteria: Parkinson's disease or Secondary Parkinsonism, diagnosed at least six months ago, in stages 1, 2 or 3 of the Hoehn and Yahr (HY) scale or with an equivalent motor condition, in the case of secondary parkinsonism; Walks with total or modified independence; Age between 40 and 70 years, under medical supervision for at least 2 months; Medical authorization for the practice of exercises; Makes regular use of antiparkinsonian medication.

Exclusion criteria

Exclusion criteria: Surgery for Parkinsonism; Cardiovascular diseases or musculoskeletal disorders (rheumatological, orthopedic, traumatological, arthrodesis) that contraindicate physical exercise; Great limitation of joint movement in any body segment; Secondary balance disorders, such as severe vestibulopathies; Severe cognitive impairment, which prevented the understanding of verbal instructions, confirmed by the Mini Mental State Examination (MMSE), with a score lower than 24 points (8 years of schooling), less than 18 points (4-7 years of schooling) or less than 14 points (illiterate people).

Design outcomes

Primary

Measure	Time frame
The endurance hability was measured by cronometred Five Times Sit to Stand Test (5T-SST) and by 6-minute walk test (6MWT).;Hand grip strength (right and left) was assessed, measured using a hydraulic dynamometer.;The quality of life was measured by PDQ-39 scale (Parkinson’s disease questionnaire 39 items). In each assessment, the scale was applied and then the score in each domain of quality of life was calculated.;The postural balance was measured by Timed Up and Go Test (TUGT) and Berg Balance Scale (BBS).	—

Measure

Time frame

The endurance hability was measured by cronometred Five Times Sit to Stand Test (5T-SST) and by 6-minute walk test (6MWT).;Hand grip strength (right and left) was assessed, measured using a hydraulic dynamometer.;The quality of life was measured by PDQ-39 scale (Parkinson’s disease questionnaire 39 items). In each assessment, the scale was applied and then the score in each domain of quality of life was calculated.;The postural balance was measured by Timed Up and Go Test (TUGT) and Berg Balance Scale (BBS).

—

Secondary

Measure	Time frame
Secondary outcomes are not expected.	—

Countries

Brazil

Contacts

Public ContactAurelio Barbosa

Unidade Universitária Goiânia-ESEFFEGO Universidade Estadual de Goiás

aurelio.barbosa@goias.gov.br+55-62-32013419

Outcome results

None listed

Source: REBEC (via WHO ICTRP)